Trials / Conditions / Adult Malignant Mesenchymoma
Adult Malignant Mesenchymoma
5 registered clinical trials studyying Adult Malignant Mesenchymoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced NCT01154452 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metasta NCT00720174 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft NCT00346164 | Children's Oncology Group | Phase 3 |
| Completed | Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma NCT00112463 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma NCT00003958 | Children's Oncology Group | Phase 3 |